Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension study of bosentan in idiopathic pulmonary fibrosis (IPF) after BUILD 3
2007-001741-18Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Feb 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of bosentan in idiopathic pulmonary fibrosis (IPF), sponsored by Actelion Pharmaceuticals Ltd. Started Feb 2008; status: completed.
02
Drugs
bosentan
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on 2007-001741-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001741-18.